Alphatec (ATEC) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - In Q4 2025, total revenue reached $213 million, representing a 20% year-over-year growth, with surgical revenue growing by 21% [3][6] - For the full year 2025, total revenue was $764 million, a $153 million increase year-over-year, equating to a 25% growth [4][16] - Adjusted EBITDA for Q4 was $33 million, reflecting a 61% year-over-year increase, with a margin of 16% [15][22] - Full year Adjusted EBITDA was $93 million, approximately 12% of sales, marking a significant improvement of $63 million year-over-year [17][22] Business Line Data and Key Metrics Changes - Surgical revenue for Q4 was $190 million, while EOS revenue was $23 million, with EOS revenue increasing by 14% year-over-year [6][8] - For the full year, surgical revenue was $687 million, up 26% compared to 2024, driven by a 22% increase in procedural volume [16][17] - EOS revenue for the full year was $77 million, up 15% year-over-year [16] Market Data and Key Metrics Changes - U.S. revenue per case increased by 1.4%, with lateral and cervical cases both up by 6% [7] - Same-store sales in the U.S. grew by 20% year-over-year, indicating strong growth in established territories [8] Company Strategy and Development Direction - The company is focused on creating clinical distinction through proceduralization, particularly in the lateral space, which is seen as a growth engine [24][26] - ATEC aims to expand its market share in spine surgery, particularly in lateral and deformity segments, leveraging its unique procedural ecosystem [26][28] - The company has signed an exclusive distribution partnership with Theradaptive, aiming to introduce a new bone morphogenetic protein (BMP) product to the market [32][33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the sustainability of top-line growth, driven by increasing surgeon adoption and procedural volume [8][19] - The outlook for 2026 anticipates revenue growth of 17% to approximately $890 million, with Adjusted EBITDA guidance increased to $134 million [19][22] - Management emphasized the importance of building a strong foundation for long-term profitable growth through infrastructure investments and expanding the sales force [33][34] Other Important Information - The company ended Q4 with $161 million in cash and had access to an additional $60 million in undrawn credit, totaling $221 million in available cash [18] - Free cash flow for Q4 was $8 million, marking the first full year of positive free cash flow for the company [18][19] Q&A Session Summary Question: Clarification on Q4 results and 2026 guidance - Analyst inquired about the market reaction to the earnings report and sought confirmation on revenue and EBITDA figures [38] - Management confirmed the accuracy of the reported figures and provided insights on expected seasonal revenue patterns for 2026 [41][42] Question: Attracting sales talent - Analyst asked about the company's ability to attract sales personnel and any notable strengths in specific territories [46] - Management responded that there is strong demand for the company's portfolio, indicating a favorable hiring environment [47]